David Karsenti1, Gaëlle Tharsis1, Jean-David Zeitoun1, Philippe Denis2, Bastien Perrot3, Jessica Coelho4, Guy Bellaiche4, Lionel Charbit5, Jean-Jacques Hakoune6, Sylva Doumet7, Elena Sion-Rohart7, Maryan Cavicchi1, Jacqueline Zago2. 1. a Digestive Endoscopy Unit , Pôle Digestif Paris Bercy, Clinique de Paris-Bercy , Charenton-le-Pont , France. 2. b Pathology Unit , 29 rue du Colisée, Paris , France. 3. c UMR1246-SPHERE Methods for Patient-centered Outcomes and Health Research , Nantes University , Nantes , France. 4. d Gastroenterology Unit , Hôpital Robert Ballanger , Aulnay-sous-Bois , France. 5. e Digestive Surgery Unit , Clinique du Vert-Galant , Tremblay-en-France , France. 6. f Digestive Endoscopy Unit , Hôpital privé du Val d'Yerres , Yerres , France. 7. g Gastroenterology Unit , Hôpital Villeneuve-Saint-Georges , Villeneuve-Saint-Georges , France.
Abstract
Background and Aims: Endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) has been proposed to obtain high-quality tissue samples for pancreatic tumors. We performed an observational study to compare EUS-FNB with a 20-gauge Procore® needle versus a 22-gauge Acquire® needle. Our primary endpoint was the quantity of the obtained tissue, as defined by the mean cumulative length of tissue core biopsies per needle pass. Methods: Sixty-eight EUS-FNB were consecutively performed on patients with a pancreatic mass. The choice of needle depended on availability at the time of admission: 34 punctures were performed with each needle. Histological material was studied in a blinded manner with respect to the needle, and the cumulative length of tissue core biopsies per needle pass was determined. Intraobserver and interobserver variability of this criterion was then evaluated. Results: There were no between-group differences. Histological diagnosis was achieved and core biopsy specimens were obtained in 28 out of 34 patients (82%) in the 20-gauge Procore® group and in 33 out of 34 patients (97%) in the 22-gauge Acquire® group (p = .1). The mean cumulative length of tissue core biopsies per needle pass was significantly higher with the 22-gauge Acquire® needle with 8.2 ± 4.2 mm versus 4.2 ± 3.8 mm for the 20-gauge Procore® needle (p < .01). No intra and inter-observer variability of this criterion was observed. Conclusions: Our results suggest significant differences, with a mean cumulative length of tissue core biopsies per needle pass significantly higher with the 22-gauge Acquire® needle. This simple criterion seems reliable and reproducible.
Background and Aims: Endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) has been proposed to obtain high-quality tissue samples for pancreatic tumors. We performed an observational study to compare EUS-FNB with a 20-gauge Procore® needle versus a 22-gauge Acquire® needle. Our primary endpoint was the quantity of the obtained tissue, as defined by the mean cumulative length of tissue core biopsies per needle pass. Methods: Sixty-eight EUS-FNB were consecutively performed on patients with a pancreatic mass. The choice of needle depended on availability at the time of admission: 34 punctures were performed with each needle. Histological material was studied in a blinded manner with respect to the needle, and the cumulative length of tissue core biopsies per needle pass was determined. Intraobserver and interobserver variability of this criterion was then evaluated. Results: There were no between-group differences. Histological diagnosis was achieved and core biopsy specimens were obtained in 28 out of 34 patients (82%) in the 20-gauge Procore® group and in 33 out of 34 patients (97%) in the 22-gauge Acquire® group (p = .1). The mean cumulative length of tissue core biopsies per needle pass was significantly higher with the 22-gauge Acquire® needle with 8.2 ± 4.2 mm versus 4.2 ± 3.8 mm for the 20-gauge Procore® needle (p < .01). No intra and inter-observer variability of this criterion was observed. Conclusions: Our results suggest significant differences, with a mean cumulative length of tissue core biopsies per needle pass significantly higher with the 22-gauge Acquire® needle. This simple criterion seems reliable and reproducible.
Authors: Jintao Guo; Anand V Sahai; Anthony Teoh; Paolo Giorgio Arcidiacono; Alberto Larghi; Adrian Saftoiu; Ali A Siddiqui; Brenda Lucia Arturo Arias; Christian Jenssen; Douglas G Adler; Sundeep Lakhtakia; Dong-Wan Seo; Fumihide Itokawa; Marc Giovannini; Girish Mishra; Luis Sabbagh; Atsushi Irisawa; Julio Iglesias-Garcia; Jan Werner Poley; Juan J Vila; Lachter Jesse; Kensuke Kubota; Evangelos Kalaitzakis; Mitsuhiro Kida; Mohamed El-Nady; Sh Untaro Mukai; Takeshi Ogura; Pietro Fusaroli; Peter Vilmann; Praveer Rai; Nam Q Nguyen; Ryan Ponnudurai; Chalapathi Rao Achanta; Todd H Baron; Ichiro Yasuda; Hsiu-Po Wang; Jinlong Hu; Bowen Duan; Manoop S Bhutani; Siyu Sun Journal: Endosc Ultrasound Date: 2020 Sep-Oct Impact factor: 5.628
Authors: Alexandru Constantinescu; Cristina Mădălina Ilie-Stan; Vasile Şandru; Bogdan Silviu Ungureanu; Dan Ionuţ Gheonea; Tudorel Ciurea; Oana Mihaela Plotogea; Christopher Pavel; Valentin Enache; Mihai Alexandru Munteanu; Gabriel Constantinescu Journal: Rom J Morphol Embryol Date: 2021 Jul-Sep Impact factor: 0.833